Inhibition of HLA class I antigen and mRNA expression induced by Rous sarcoma virus in transformed human fibroblasts

Area of Science:

• Immunology
• Molecular Biology
• Oncology

Background:

• Reduced Human Leukocyte Antigen (HLA) class I expression is observed in various human neoplasms.
• The underlying mechanisms for this downregulation in cancer cells require further investigation.

Purpose of the Study:

• To investigate the mechanism by which avian retroviruses reduce HLA class I antigen expression in human fibroblasts.
• To determine if Rous sarcoma virus (RSV) integration affects HLA gene expression and protein synthesis.

Main Methods:

• Human dermal fibroblasts were transformed in vitro using Rous sarcoma virus (RSV).
• Clonal cell lines were established and analyzed for cell-surface HLA class I (HLA-A, -B, -C) and beta 2-microglobulin expression.
• Intracellular synthesis, RNA transcript levels (RNA gel blot), and genomic DNA (Southern blot) were assessed.

Main Results:

• Transformed fibroblasts exhibited reduced expression of cell-surface HLA class I antigens and beta 2-microglobulin compared to parental cells.
• A decrease in intracellular synthesis and HLA class I transcript levels was observed in RSV-transformed cells.
• Genomic Southern blot analysis showed no alterations in HLA gene structure in infected cells.

Conclusions:

• Rous sarcoma provirus integration negatively controls HLA class I gene expression at the transcriptional level.
• The findings suggest a mechanism independent of alterations in the HLA gene locus itself.
• This study provides insights into how viral infections can modulate immune recognition molecules in cancer.